| Course Name | Fees | Eligibility |
| M.B.A. (Master of Business Administration) | ₹1,04,010 | Bachelor's degree in Pharmacy, Medicine, Engineering, or related discipline, Valid GPAT/GATE/NET scorecard, Minimum 60% aggregate marks or equivalent CGPA, Minimum 55% aggregate marks or equivalent CGPA for SC/ST category |
| M.Tech. (Master of Technology) | ₹94,744 | Bachelor's degree in Pharmacy or Pharmaceutical Sciences, Minimum 55% aggregate marks or equivalent CGPA |
| M.Pharm. (Master of Pharmacy) | Bachelor's degree in Pharmacy (B.Pharm.), Minimum aggregate score of 60%, Valid GPAT score, Valid GATE score, Age criteria as per guidelines | |
| Ph.D. (Doctor of Philosophy) | ₹2,23,678 | Master's degree in Pharmacy, Master's degree in Pharmaceutical Sciences, Master's degree in Chemical Sciences, Master's degree in Biological Sciences, Bachelor's degree in Pharmacy, Master's degree in Chemistry, Master's degree in Life Sciences, minimum of 60% marks, CGPA of 6.75 (on a 10-point scale) in qualifying degree |
| M.S. (Master of Science) | ₹94,744 - 1,54,000 | 60% aggregate marks or equivalent grade in Bachelor's degree in Pharmacy, Pharmaceutical Sciences, or Medicine (MBBS/BDS), Master's degree in Chemistry or Life Sciences, valid GATE or GPAT score, qualifying score in NIPER Joint Entrance Examination (NIPER JEE) |
NIPER Mohali cutoffs for 2026 are projected to tighten further, narrowing by 10–20 ranks across most branches compared to 2025, mainly due to an anticipated 13,500+ applicants, stronger GPAT participation, and the institute’s consistently high preference among top rankers despite a fixed 450-seat matrix. For the general category, highly competitive programs like Pharmacology are expected to conclude around AIR 35–40, while Pharmaceutics may close between AIR 70–90, reflecting rising interest in R&D-driven fields.
Among reserved categories, OBC cutoffs are likely to fall in the 90–130 range, with branches such as Pharmaceutics and Biotechnology filling early, whereas SC cutoffs may cluster around AIR 280–320 due to steady demand and category seat limits. Considering the moderate-to-difficult pattern of recent NIPER JEE exams and the trend of tighter ranks, aspirants aiming for top programs should target 80+ marks out of 200 to consistently position themselves within the top 100 ranks, ensuring a strong margin for securing core specializations at NIPER Mohali.
NIPER Mohali’s expected 2026 cutoffs indicate slightly tighter ranks than 2025, driven by higher applicant numbers and steady seat availability. Pharmacology, Pharmaceutics, and MBA (Pharm.) show predictable trends with marks near the 80+/200 range for top ranks.
| Category / Branch | Expected Cutoff 2026 |
|---|---|
| General (Overall) | 10–20 ranks tougher than 2025 |
| General – Pharmacology | Rank 35–40 |
| General – Marks | 80+/200 for top ranks |
| OBC – Pharmacology | Rank 90–130 |
| SC Category | Rank 280–320 |
| Pharmaceutics (General) | Rank 70–90 |
| MBA (Pharm.) | Rank ~200 |
| Prep Focus | Pharma Analysis (50% weightage) |
The general category cutoffs for NIPER Mohali in 2025 tightened significantly, with admissions closing under AIR 250 for all major MS (Pharm) and MBA programs. Increased applicant competition and higher preference for Mohali’s research ecosystem pushed closing ranks 50 spots tighter than 2024.
| Branch | Closing Rank (Round 3) |
|---|---|
| MS (Pharm) Pharmacology | 45 |
| MS (Pharm) Pharmaceutics | 80 |
| MS (Pharm) Biotechnology | 120 |
| MS (Pharm) Natural Products | 160 |
| MS (Pharm) Pharmaceutical Analysis | 200 |
| MBA (Pharm) | 220 |
| MS (Pharm) Regulatory Toxicology | 250 |
NIPER Mohali’s OBC Round-3 cutoffs show highest competition in core branches, with Pharmacology closing at Rank 100 and Pharmaceutics at 150. Non-core programs like MBA (Pharm) and Regulatory Toxicology closed at wider ranks up to 450.
| Branch | Closing Rank (Round 3) |
|---|---|
| MS (Pharm) Pharmacology | 100 |
| MS (Pharm) Pharmaceutics | 150 |
| MS (Pharm) Biotechnology | 220 |
| MBA (Pharm) | 350 |
| MS (Pharm) Regulatory Toxicology | 450 |
The SC/ST cutoffs for NIPER Mohali 2025 show a wider rank range, with SC admissions closing between AIR 300–1,200 and ST between AIR 600–1,800 across major branches. Core programs like Pharmacology and Pharmaceutics remained the most competitive, while branches such as Biotechnology and Natural Products saw relatively easier entry for reserved category candidates.
| Branch | SC Closing Rank | ST Closing Rank |
|---|---|---|
| Pharmacology | 300 | 600 |
| Pharmaceutics | 500 | 900 |
| Biotechnology | 800 | 1,200 |
| Natural Products | 900 | 1,400 |
| Regulatory Toxicology | 1,200 | 1,800 |
NIPER Mohali’s 2025 cutoffs varied sharply between core and non-core branches, with Pharmacology and Pharmaceutics closing significantly tighter due to concentrated demand. Emerging and professional programs saw broader cutoff ranges, offering flexible entry for diverse career goals.
| Branch Type | Example Branches | General Cutoff Range (2025) |
|---|---|---|
| Core | Pharmacology, Pharmaceutics | 45 – 120 |
| Emerging | Biotechnology, Natural Products | 120 – 200 |
| Professional | MBA (Pharm), Regulatory Toxicology | 200 – 350 |
Cutoff trends across 2022–2024 show a clear tightening as applicant numbers rose and competition intensified. Core pharmaceutical branches consistently saw stronger ranks, while professional programs maintained moderate gaps.
| Branch | 2022 General | 2023 General | 2024 General |
|---|---|---|---|
| Pharmacology | 60 | 55 | 50 |
| Pharmaceutics | 100 | 90 | 85 |
| Biotechnology | 150 | 140 | 130 |
| MBA (Pharm) | 280 | 260 | 250 |
Mohali (Punjab)
Mohali (Punjab)
Mohali (Punjab)